|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date27 May 1983 |
盐酸氨溴索口服缓释混悬液治疗下呼吸道疾病伴有痰液粘稠的随机、双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial of ambroxol hydrochloride oral sustained-release suspension in the treatment of lower respiratory tract diseases with thick sputum
评价盐酸氨溴索口服缓释混悬液治疗下呼吸道疾病伴有痰液粘稠的有效性和安全性
[Translation] To evaluate the efficacy and safety of ambroxol hydrochloride oral extended-release suspension in the treatment of lower respiratory tract diseases with thick sputum
100 Clinical Results associated with Maoming Dianbai District Global Medicine Co., Ltd.
0 Patents (Medical) associated with Maoming Dianbai District Global Medicine Co., Ltd.
100 Deals associated with Maoming Dianbai District Global Medicine Co., Ltd.
100 Translational Medicine associated with Maoming Dianbai District Global Medicine Co., Ltd.